Circassia Pharmaceuticals's total assets for Q2 2025 were £71.00M, an increase of 3.80% from the previous quarter. GB:NIOX total liabilities were £6.60M for the fiscal quarter, a -25.84% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.